Successful mTOR inhibitor therapy for a metastastic neuroendocrine tumour in a patient with a germline TSC2 mutation
Standard
Successful mTOR inhibitor therapy for a metastastic neuroendocrine tumour in a patient with a germline TSC2 mutation. / Schrader, J; Henes, F O; Perez, D; Burdak-Rothkamm, S; Stein, A; Izbicki, J R; Lohse, A W.
in: ANN ONCOL, Jahrgang 28, Nr. 4, 01.04.2017, S. 904-905.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Successful mTOR inhibitor therapy for a metastastic neuroendocrine tumour in a patient with a germline TSC2 mutation
AU - Schrader, J
AU - Henes, F O
AU - Perez, D
AU - Burdak-Rothkamm, S
AU - Stein, A
AU - Izbicki, J R
AU - Lohse, A W
N1 - Letter
PY - 2017/4/1
Y1 - 2017/4/1
KW - Journal Article
U2 - 10.1093/annonc/mdx007
DO - 10.1093/annonc/mdx007
M3 - Other (editorial matter etc.)
C2 - 28327903
VL - 28
SP - 904
EP - 905
JO - ANN ONCOL
JF - ANN ONCOL
SN - 0923-7534
IS - 4
ER -